NorthRock Partners’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.9K | Buy |
1,524
+3
| +0.2% | +$122 | ﹤0.01% | 751 |
|
|
2025
Q1 | $66.6K | Buy |
1,521
+6
| +0.4% | +$263 | ﹤0.01% | 656 |
|
|
2024
Q4 | $65.1K | Buy |
1,515
+5
| +0.3% | +$215 | ﹤0.01% | 636 |
|
|
2024
Q3 | $67K | Buy |
1,510
+7
| +0.5% | +$311 | ﹤0.01% | 676 |
|
|
2024
Q2 | $59.8K | Buy |
1,503
+5
| +0.3% | +$199 | ﹤0.01% | 647 |
|
|
2024
Q1 | $64.6K | Sell |
1,498
-114
| -7% | -$4.92K | ﹤0.01% | 645 |
|
|
2023
Q4 | $67.1K | Buy |
+1,612
| New | +$67.1K | ﹤0.01% | 604 |
|